Drug
Pozelimab
Pozelimab: highest development phase Phase 3, developed by Regeneron. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pozelimab NCT06541704 | Phase 3 | Age-related Macular Degeneration (AMD) |
| Pozelimab NCT04601844 | Phase 1 | Healthy |
Latest
No recent events.
Follow Pozelimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.